This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of active pharmaceutical ingredients (APIs). Its structural features, including the difluoromethyl and fluorophenyl groups, make it valuable in the development of drugs targeting specific biological pathways. It is often employed in the creation of small molecule inhibitors, particularly in the field of oncology and neurology, where its chiral center can influence the efficacy and selectivity of the final drug product. Additionally, its unique chemical structure allows for the exploration of novel therapeutic agents with potential applications in treating diseases such as cancer, neurodegenerative disorders, and inflammatory conditions.